#$%^&*AU2018271420A120181220.pdf#####Optimized Monoclonal Antibodies against Tissue Factor Pathway Inhibitor (TFPI) Abstract Isolated monoclonal antibodies that bind human tissue factor pathway inhibitor (TFPI) are provided. Isolated nucleic acid molecules encoding monoclonal antibodies that bind TFPI are also contemplated. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided. Methods of producing the antibodies are also provided. H: fint Interwoven NRPortbl DCC FMT 12333673 1.docx -9/12/16
